Ivan Bieche

发表

High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.

Didier Marot, Rosette Lidereau, M. Perricaudet, 2007, Endocrine-related cancer.

BMC Cancer BioMed Central Research article NF-kappa B genes have a major role in Inflammatory Breast Cancer

Rosette Lidereau, M. Espié, S. Vacher, 2008 .

Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer

Antonin Morillon, Rosette Lidereau, Didier Meseure, 2016, British Journal of Cancer.

Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines

I. Bièche, E. Raymond, S. Faivre, 2008, Cancer Chemotherapy and Pharmacology.

Identification of 5 novel genes methylated in breast and other epithelial cancers

David Euhus, J. Minna, L. Hesson, 2010, Molecular Cancer.

Ex Vivo Priming of Endothelial Progenitor Cells With SDF-1 Before Transplantation Could Increase Their Proangiogenic Potential

F. Fauvel-Lafève, I. Bièche, I. Laurendeau, 2008, Arteriosclerosis, thrombosis, and vascular biology.

Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels.

I. Bièche, M. Perrot-Applanat, S. Mourah, 2008, The American journal of pathology.

miRNA expression profiling of inflammatory breast cancer identifies a 5‐miRNA signature predictive of breast tumor aggressiveness

Rosette Lidereau, S. Vacher, I. Bièche, 2013, International journal of cancer.

Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity.

C. Ricketts, S. Vacher, I. Bièche, 2011, Cancer research.

Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways

I. Bièche, C. Dumontet, J. Vendrell, 2010, International journal of cancer.